Clearstead Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $167K | Buy |
646
+626
| +3,130% | +$162K | ﹤0.01% | 923 |
|
|
2025
Q1 | $4.48K | Sell |
20
-236
| -92% | -$52.9K | ﹤0.01% | 1768 |
|
|
2024
Q4 | $58.6K | Sell |
256
-31
| -11% | -$7.1K | ﹤0.01% | 1127 |
|
|
2024
Q3 | $70K | Sell |
287
-286
| -50% | -$69.8K | ﹤0.01% | 1122 |
|
|
2024
Q2 | $110K | Buy |
573
+1
| +0.2% | +$191 | ﹤0.01% | 977 |
|
|
2024
Q1 | $125K | Sell |
572
-34
| -6% | -$7.41K | 0.01% | 559 |
|
|
2023
Q4 | $104K | Sell |
606
-580
| -49% | -$99.8K | 0.01% | 576 |
|
|
2023
Q3 | $175K | Buy |
1,186
+626
| +112% | +$92.5K | 0.01% | 597 |
|
|
2023
Q2 | $122K | Buy |
560
+359
| +179% | +$78.4K | 0.01% | 527 |
|
|
2023
Q1 | $44K | Buy |
201
+18
| +10% | +$3.94K | ﹤0.01% | 690 |
|
|
2022
Q4 | $38.1K | Hold |
183
| – | – | ﹤0.01% | 666 |
|
|
2022
Q3 | $40K | Hold |
183
| – | – | ﹤0.01% | 650 |
|
|
2022
Q2 | $38K | Hold |
183
| – | – | ﹤0.01% | 673 |
|
|
2022
Q1 | $44K | Hold |
183
| – | – | ﹤0.01% | 709 |
|
|
2021
Q4 | $48K | Sell |
183
-8
| -4% | -$2.1K | ﹤0.01% | 660 |
|
|
2021
Q3 | $50K | Hold |
191
| – | – | ﹤0.01% | 611 |
|
|
2021
Q2 | $47K | Buy |
191
+8
| +4% | +$1.97K | ﹤0.01% | 567 |
|
|
2021
Q1 | $36K | Hold |
183
| – | – | ﹤0.01% | 585 |
|
|
2020
Q4 | $39K | Hold |
183
| – | – | ﹤0.01% | 546 |
|
|
2020
Q3 | $31K | Hold |
183
| – | – | ﹤0.01% | 536 |
|
|
2020
Q2 | $35K | Hold |
183
| – | – | ﹤0.01% | 472 |
|
|
2020
Q1 | $27K | Buy |
+183
| New | +$27K | ﹤0.01% | 476 |
|